Australia's Genetic Signatures set for best day on sales growth
** Shares of Genetic Signatures GSS.AX rise as much as 58.3% to A$0.38, their highest level since July 23 and on track for best day ever ** Specialist molecular diagnostics co reports quarterly sales of A$5.4 million ($3.51 million), up 15% pcp ** About 866,000 shares change hands, 5.7 times the 30-day avg ** Stock down 39.7% YTD, including the session's moves ($1 = 1.5389 Australian dollars) (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes